Arcutis Biotherapeutics, Inc.
ARQT · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $376M | $197M | +91.3% |
| Operating income | −$12.2M | −$128M | +90.5% |
| Net income | −$16.1M | −$140M | +88.5% |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 4, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $144M | $99.2M | +45.1% |
| Operating income | $9.40M | $8.50M | +10.6% |
| Net income | $8.80M | $7.40M | +18.9% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was Arcutis's revenue in FY2025?
- $376M in FY2025 (Fiscal year ended Dec 31, 2025), +91.3% vs $197M a year earlier, per its 10-K filed Feb 2026.
- Was Arcutis profitable in FY2025?
- No: net income was −$16.1M and operating income −$12.2M in FY2025.
- What was Arcutis's revenue in Q3 2026?
- $144M (+45.1% vs a year earlier), per its Form 10-Q filed Nov 4, 2026.